loader from loading.io

In the News... Insulin coverage changes, CGM use in older people, another company joins islet cell research and more!

Diabetes Connections | Type 1 Diabetes

Release Date: 07/22/2022

What’s ahead for Tandem Diabetes? An update on pumps, CGMs, infusion sets, and more! show art What’s ahead for Tandem Diabetes? An update on pumps, CGMs, infusion sets, and more!

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections, Tandem Diabetes made some big announcements at the recent ADA Conference – we’re going behind the headlines and asking your questions about Control IQ updates, extended wear infusion sets, what’s happening with their patch pumps, and a lot more. I’m talking to Ben Mar the Director of Product marketing. We also getting into their expanded partnership with Abbott – in additional to the Libre 3 plus, they’re one of the pump companies that has signed on for the future glucose/ketone sensor. A lot to get to here! This podcast is not intended as medical...

info_outline
In the News...Top Stories from ADA and more! show art In the News...Top Stories from ADA and more!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: loads of news from American Diabetes Association Scientific Sessions, GLP1 for T1D, Tech updates, diabetes in space, and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more about everything at our home page  Reach...

info_outline
Still Not Waiting: Lane Desborough's Bold New Push with Nudge show art Still Not Waiting: Lane Desborough's Bold New Push with Nudge

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections, “We are not waiting” became more than just a slogan — it sparked a movement. Back when the diabetes community was fed up with slow progress, DIYers stepped in with solutions that actually worked better than what companies were offering. That rallying cry? It came from Lane Desborough in 2013. And more than a decade later, he’s still challenging the status quo. We’re catching up with Lane to talk about his latest project, Nudge — much more than just another insulin pump algorithm, it’s an innovation to create more open and accessible systems This...

info_outline
Cloak the Poke: A New Way to  Make Shots Less Scary show art Cloak the Poke: A New Way to Make Shots Less Scary

Diabetes Connections | Type 1 Diabetes

As we gear up for ADA Scientific Sessions and get ready to hear studies and reports from the big diabetes companies, I’ve decided to highlight something on the other end of the spectrum. College students, seeing a need and developing a solution. Cloak The Poke is all about addressing fear of needles, especially in kids. We’ll explain how it works,  more about the team behind it, and their big goals going forward. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about Join us at  Please visit...

info_outline
In the News... Omnipod updates, Tandem + Abbott, Dr. Pepper Zero recall, American Ninja and more! show art In the News... Omnipod updates, Tandem + Abbott, Dr. Pepper Zero recall, American Ninja and more!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: what is adaptive biobehavioral control for AID systems? Omnipod 5 launches iOS app with Dexcom G7 compatability and a comic book(?!), Tandem and Abbott announce new partnership, Katie Bone is back on American Ninja Warrior, and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our...

info_outline
GLP-1 Medications for T1D:  What your endo wants you to know show art GLP-1 Medications for T1D: What your endo wants you to know

Diabetes Connections | Type 1 Diabetes

More and more people with type 1 are using GLP-1 receptor agonists. You know these medications, with brand names like Ozempic, Mounjaro, Wegovy and Zepbound, but none of them are specifically approved to treat T1D. Some of the first studies are underway to study the safety and effectiveness of GLP-1s, but that hasn’t stopped thousands of using them off-label or to treat obesity. We’re talking to an endocrinologist and a clinical pharmacist about why they prescribe these meds to some of their type 1 patients, who they won’t prescribe them for, and – I know you’re already asking –...

info_outline
Why Diabetes Camp Matters More Than Ever:  A Conversation with DECA’s Lisa Gier show art Why Diabetes Camp Matters More Than Ever: A Conversation with DECA’s Lisa Gier

Diabetes Connections | Type 1 Diabetes

It’s time to talk about summer camp! Kids may be getting ready to go, already there, or maybe you’re an adult with type 1 who has fond memories or is working at camp.  We’re talking to the which serves the diabetes camp community. Lisa Gier is the executive direction of DECA – she lives with type 1, attended camp and her son who also has T1D now goes to the camp she attended as a child. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at  Please visit our Sponsors &...

info_outline
Tubeless, smarter & interoperable: A look into Medtronic’s future plans show art Tubeless, smarter & interoperable: A look into Medtronic’s future plans

Diabetes Connections | Type 1 Diabetes

A conversation with a Medtronic engineer who’s been with the company since the beginning of the Artificial Pancreas project. Lou Lintereur is now Chief Engineer for AID systems at Medtronic.. we talk about the recently approved Simplera Sync Sensor, changes coming to Medtronic pumps, he answers your questions about AI use, patch pumps, and the idea of a pump that needs zero user interaction. Note: this episode was recorded before Medtronic's announcement that they will spin off the Diabetes division. This podcast is not intended as medical advice. If you have those kinds of questions, please...

info_outline
"The Worst Game Ever" - Sam Glassenberg wants to change how we learn about T1D

Diabetes Connections | Type 1 Diabetes

Learning through video games isn’t new – there are games aimed at almost every profession, even healthcare.  Sam Glassenberg is the founder of Level Ex which makes those types of learning games –  and when his daughter was diagnosed with type 1.. he was appalled at the on-boarding process which he called the worst game ever, full of frustration and punishment for the patient and caregiver. So Sam developed Level One – a new free game to teach type 1. We’re talking about how it works, who it’s for, and what makes it different from those gamification flops you may remember...

info_outline
In the News...Tandem's new infusion set approved, Sernova cell-pouch moves forward, GLP-1 meds for T1D, and more! show art In the News...Tandem's new infusion set approved, Sernova cell-pouch moves forward, GLP-1 meds for T1D, and more!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Tandem's new infusion set is approved, Dexcom G7 compatibility with the Omnipod 5 iPhone app announced, Sernova cell-pouch moves forward, GLP-1 meds for T1D, and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more...

info_outline
 
More Episodes

Top stories In the News this week, United Healthcare announces changes to how they cover insulin for some, a new study looks at CGM use in people with type 2 over the age of 65, another company begins islet cell clinical trials, a new tool to treat diabetic neuropathy pain, gestational diabetes is on the rise, and more.

Learn more about the T1D Exchange: https://t1dexchange.org/stacey/

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Episode Transcription Below (or coming soon!)

Please visit our Sponsors & Partners - they help make the show possible!

*Click here to learn more about OMNIPOD*

*Click here to learn more about AFREZZA*

*Click here to learn more about DEXCOM*

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.
XX
In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population.
https://t1dexchange.org/stacey/
XX
Our top story.. United Healthcare says it will have no “out of pocket” expenses for insulin starting January first. It’s doing the same for other critical drugs like glucagon, epinephrine and albuterol. Looking into this a bit more, though, it’s not the boon it first seems. This only covers certain eligible patients. Stat news says about a quarter of United Healthcare’s patients will qualify but I saw a few commentators say it could actually be less than 5-percent. UnitedHealth Group shared that it earned $5.1 billion in profit for the second quarter of 2022.

https://kstp.com/kstp-news/top-news/united-healthcare-says-no-out-of-pocket-expenses-for-insulin/
XX
Not too surprising but a good study about people with type 2 using CGMs. This was for people using basal insulin only and over 65 years old. They found when given a CGM, their A1Cs went down an average of 1 full point with fewer lows. These are the kinds of studies that may seem obvious to us but that are needed to show insurers they need to cover.
https://www.liebertpub.com/doi/10.1089/dia.2021.0494
XX
New device approved to treat pain associated with diabetic peripheral neuropathy. The DyAnsys’ First Relief system is set behind the ear – its an adhesive, nothing surgical. It features three small, acupuncturelike needles that reach through the skin behind the ear to access the nervous system. Once in place, the device continuously emits low-level electrical pulses over the course of several days at a time; the FDA cleared the system for repeated treatments spanning up to eight weeks.
https://www.fiercebiotech.com/medtech/fda-clears-wearable-neurostimulator-dyansys-treat-pain-diabetic-nerve-damage
XX
Another company having success with islet cell transplants. ProtoKinetix announced they’re completely safety objectives and will start phase 1 clinical trials of their molecule PKX-001. Not much to report here yet, but I didn’t want to news of the Vertex/Viactye merger to over shadow that there are other efforts going on here.

https://www.businesswire.com/news/home/20220720005086/en/ProtoKinetix-Successfully-Completes-Phase-1-Clinical-Trials-for-the-Treatment-of-Type-1-Diabetes-in-Islet-Cell-Transplants
XX
Roche and Insulet settle their lawsuit.. this was a patent issue and both companies were suing each other. Insulet will give Roche 20-million dollars and Roche has agreed not to sue Insulet for five years. This was set to go to trial next week.
https://seekingalpha.com/news/3855728-insulet-to-pay-20m-to-settle-patent-lawsuit
XX
Gestational diabetes is on the rise, climbing 30% between 2016 and 2020, according to a new study by the Centers for Disease Control and Prevention.The CDC analysis showed that cases increased 13% during the first year of the pandemic alone, a much larger spike than the previous annual increases of about 5%. Experts say that the sharp increase during Covid may be because the disease accelerated people’s adoption of a sedentary lifestyle and led to pandemic-related physical and emotional stress. experts are concerned outcomes in 2021 may be worse, when Covid hit harder.
If anything, the authors and experts said, the new finding is likely an undercount. Relying on birth certificate data, which the CDC study did, can miss cases that are not captured by a physician on those forms. “If you think about it, somebody who’s doing 20 deliveries in a night, or ten deliveries in a night, is just kind of trying to get those reports and certificates out there,” said Morgan. “They’re not paying as much attention to some of those details.”

https://www.statnews.com/2022/07/20/as-diabetes-during-pregnancy-grows-more-common-experts-point-to-a-need-for-preventive-care/
XX
Right back to the news in a moment but first As I mentioned, The T1D Exchange Registry is an online research study, designed to harness the power of individuals with type 1 diabetes. It’s a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy Sign up at T1DExchange.org slash Stacey (that’s S-T-A-C-E-Y).
XX
/about-us/
XX

Next week on the podcast I’m talking to Sebastien Sasseville who recently completey the absolutely exhausting sounding Race Across America. We’ll talk about how you manage type 1 – and everything else – when you’re spending more than 20 hours a day on a bike for 12 days! The long format episode out right now is with the folks at Diabetes Wise – that’s a website to help you choose diabetes technology.. they’ve added information for doctors – this may help you educate your heathcare providers on why you want the pump or cgm system that you do..
Listen wherever you get your podcasts
That’s In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.